SIC
ROIV icon

SJS Investment Consulting’s Roivant Sciences ROIV Stock Holding History

SJS Investment Consulting’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.54K Buy
213
+40
+23% +$1.18K ﹤0.01% 1201
2026
Q1 		$4.79K Sell
173
-157
-48% -$4.03K ﹤0.01% 1046
2025
Q4 		$7.16K Buy
330
+309
+1,471% +$6.1K ﹤0.01% 867
2025
Q3 		$318 Buy
+21
New +$260 ﹤0.01% 1354

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PDM
Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

SJS Investment Consulting's ROIV Position: Q2 2026 in Review

SJS Investment Consulting increased its Roivant Sciences (ROIV) stake by 23% in Q2 2026, buying an estimated $1.18K and bringing the position to 213 shares worth $7.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

SJS Investment Consulting first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 235 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • SJS Investment Consulting held 213 shares of Roivant Sciences worth $7.54K as of Q2 2026.
  • SJS Investment Consulting bought 40 Roivant Sciences shares in Q2 2026, an estimated $1.18K.
  • Roivant Sciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1201 holding.
  • SJS Investment Consulting first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • 235 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.